CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...